Giuseppe Lamberti

How does adding PD-(L)1 inhibitors to platinum-etoposide treatment of small cell lung cancer improve survival outcomes?

1. The introduction of immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis has improved survival outcomes in patients with both extensive stage (ES, 60-70% of cases) and limited stage...